Hubertus Pietsch Selected Research

Hubertus Pietsch Research Topics

Disease

25	Body Weight (Weight, Body) 10/2022 - 01/2008
14	Neoplasms (Cancer) 10/2022 - 05/2009
10	Nephrogenic Fibrosing Dermopathy 01/2017 - 01/2008
2	Brain Neoplasms (Brain Tumor) 11/2019 - 01/2017
2	Hypoxia (Hypoxemia) 05/2012 - 02/2009
2	Carcinoma (Carcinomatosis) 04/2012 - 02/2012
2	Vascular System Injuries 12/2009 - 12/2007
2	Fibrosis (Cirrhosis) 08/2009 - 01/2008
1	Glioblastoma (Glioblastoma Multiforme) 10/2022
1	Pathologic Constriction (Stenosis) 01/2021
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2021
1	Atherosclerotic Plaque (Atheroma) 01/2021
1	Gliosarcoma 11/2019
1	Angioedema 12/2014
1	Glioma (Gliomas) 08/2014
1	Pulmonary Embolism 08/2013
1	Breast Neoplasms (Breast Cancer) 02/2013
1	Lung Neoplasms (Lung Cancer) 11/2012
1	Acute Kidney Injury (Acute Renal Failure) 09/2012
1	Teratoma (Teratoid Tumor) 07/2012
1	Teratocarcinoma 07/2012
1	Neoplasm Metastasis (Metastasis) 08/2011
1	Renal Insufficiency (Renal Failure) 05/2010
1	Thrombosis (Thrombus) 12/2009
1	Chromosome Aberrations (Chromosome Abnormalities) 02/2009
1	Infarction (Infarctions) 02/2009
1	Myocardial Infarction 02/2009
1	Arthritis (Polyarthritis) 05/2007

Drug/Important Bio-Agent (IBA)

21	Contrast MediaIBA 01/2021 - 01/2008
15	IodineIBA 01/2022 - 02/2009
11	GadoliniumIBA 01/2021 - 01/2008
11	iopromide (Ultravist)FDA Link 12/2020 - 02/2009
6	gadobutrolIBA 10/2022 - 02/2012
5	iodixanol (Visipaque)FDA Link 12/2014 - 02/2009
4	gadodiamide (Omniscan)FDA Link 01/2022 - 01/2008
4	Gadolinium DTPA (Magnevist)FDA Link 09/2018 - 01/2008
3	gadolinium ethoxybenzyl DTPA FDA Link 01/2021 - 09/2018
2	regorafenibIBA 08/2014 - 10/2013
2	LigandsIBA 01/2011 - 05/2008
1	OxidesIBA 01/2021
1	BismuthIBA 01/2021
1	CalciumIBA 01/2021
1	HafniumIBA 01/2021
1	HolmiumIBA 01/2021
1	IronIBA 01/2021
1	TungstenIBA 01/2021
1	ChloridesIBA 01/2020
1	GasesIBA 09/2018
1	iotrolan (Isovist)FDA Link 12/2014
1	Coloring Agents (Dyes)IBA 12/2014
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 12/2014
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 08/2013
1	gadoterate meglumineIBA 02/2013
1	A-factor (Streptomyces)IBA 02/2013
1	Plasminogen Activator Inhibitor 1IBA 09/2012
1	Lipocalin-2IBA 09/2012
1	EndoglinIBA 07/2012
1	ImmunosorbentsIBA 07/2012
1	AcidsIBA 07/2012
1	EnzymesIBA 07/2012
1	ferric oxide (iron oxide)IBA 07/2012
1	iomeprolIBA 04/2012
1	AntigensIBA 02/2012
1	Sorafenib (BAY 43-9006)FDA Link 02/2012
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 02/2012
1	Lanthanoid Series Elements (Lanthanides)IBA 11/2011
1	ElementsIBA 11/2011
1	Erythropoietin FDA Link 12/2009
1	ZincIBA 08/2009
1	IonsIBA 08/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2009
1	Bevacizumab (Avastin)FDA Link 05/2009
1	PEG12000-Gen4-triiodoIBA 05/2009
1	Iohexol (Omnipaque)FDA Link 05/2009
1	Pharmaceutical PreparationsIBA 05/2009
1	Angiogenesis InhibitorsIBA 05/2009
1	Biological ProductsIBA 02/2009
1	Biomarkers (Surrogate Marker)IBA 02/2009
1	gadolinium EDTAIBA 01/2008
1	gadofluorineIBA 05/2007

Therapy/Procedure

6	Intravenous Injections 01/2017 - 01/2008
6	Therapeutics 10/2013 - 05/2007
3	Radiotherapy 11/2019 - 06/2009
2	Injections 01/2022 - 01/2020
1	DF protocol 12/2020
1	CT protocol 11/2012
1	Drug Therapy (Chemotherapy) 04/2012
1	Stents 12/2007